A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice

PLoS Currents

Volumn , Issue , 2012, Pages

  Selsby, Joshua ^a   Morris, Carl ^b   Morris, Linda ^c   Sweeney, Lee ^c  

^a IOWA STATE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DYSTROPHIN; EVANS BLUE; PROTEASOME; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DYSTROPHY; HYPOTHESIS; MALE; MOUSE; MUSCLE DISEASE; MUSCLE FUNCTION; NONHUMAN; PATHOLOGY; PROTEIN EXPRESSION; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL TISSUE; BODY MASS; EXTENSOR DIGITORUM LONGUS MUSCLE; MEMBRANE DAMAGE; MUSCLE CONTRACTION; MUSCLE MASS; TENSION; PROTEIN DEFICIENCY;

EID: 84867444389     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/4f84a944d8930     Document Type: Article

References (15)

1. Morris CA, Selsby JT, Morris LD, Pendrak K, Sweeney HL. Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice. J Appl Physiol. 2010 Nov;109(5):1492-9. PubMed PMID:20847128.
2. Selsby J, Pendrak K, Zadel M, Tian Z, Pham J, Carver T, Acosta P, Barton E, Sweeney HL. Leupeptin-based inhibitors do not improve the mdx phenotype. Am J Physiol Regul Integr Comp Physiol. 2010 Nov;299(5):R1192-201. PubMed PMID:20844259.
3. Selsby JT. Increased catalase expression improves muscle function in mdx mice. Exp Physiol. 2011 Feb;96(2):194-202. PubMed PMID:21041317.
4. Briguet A, Erb M, Courdier-Fruh I, Barzaghi P, Santos G, Herzner H, Lescop C, Siendt H, Henneboehle M, Weyermann P, Magyar JP, Dubach-Powell J, Metz G, Meier T. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse. FASEB J. 2008 Dec;22(12):4190-200. PubMed PMID:18728218.
5. Spencer MJ, Croall DE, Tidball JG. Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem. 1995 May 5;270(18):10909-14. PubMed PMID:7738032.
6. Disatnik MH, Dhawan J, Yu Y, Beal MF, Whirl MM, Franco AA, Rando TA. Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J Neurol Sci. 1998 Nov 26;161(1):77-84. PubMed PMID:9879685.
7. Tidball JG, Albrecht DE, Lokensgard BE, Spencer MJ. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci. 1995 Jun;108 (Pt 6):2197-204. PubMed PMID:7673339.
8. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A. 1984 Feb;81(4):1189-92. PubMed PMID:6583703.
9. Badalamente MA, Stracher A. Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve. 2000 Jan;23(1):106-11. PubMed PMID:10590413.
10. Spencer MJ, Mellgren RL. Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum Mol Genet. 2002 Oct 1;11(21):2645-55. PubMed PMID:12354790.
11. Gazzerro E, Assereto S, Bonetto A, Sotgia F, Scarfì S, Pistorio A, Bonuccelli G, Cilli M, Bruno C, Zara F, Lisanti MP, Minetti C. Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies. Am J Pathol. 2010 Apr;176(4):1863-77. PubMed PMID:20304949.
12. Assereto S, Stringara S, Sotgia F, Bonuccelli G, Broccolini A, Pedemonte M, Traverso M, Biancheri R, Zara F, Bruno C, Lisanti MP, Minetti C. Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment. Am J Physiol Cell Physiol. 2006 Feb;290(2):C577-82. PubMed PMID:16192300.
13. Bonuccelli G, Sotgia F, Schubert W, Park DS, Frank PG, Woodman SE, Insabato L, Cammer M, Minetti C, Lisanti MP. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. Am J Pathol. 2003 Oct;163(4):1663-75. PubMed PMID:14507673.
14. Bonuccelli G, Sotgia F, Capozza F, Gazzerro E, Minetti C, Lisanti MP. Localized treatment with a novel FDAapproved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice. Cell Cycle. 2007 May 15;6(10):1242-8. PubMed PMID:17495527.
15. Morine KJ, Bish LT, Selsby JT, Gazzara JA, Pendrak K, Sleeper MM, Barton ER, Lee SJ, Sweeney HL. Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy. Muscle Nerve. 2010 Nov;42(5):722-30. PubMed PMID:20730876.